Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1973 May;118(5):6–11.

Alternate immunoprophylactic and biologic techniques in the control of viral respiratory tract diseases.

J W Geme Jr
PMCID: PMC1455052  PMID: 4354510

Full text

PDF
6

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ana P. P., Arrobio J. O., Kim H. W., Brandt C. D., Chanock R. M., Parrott R. H. Serum complement in acute bronchiolitis. Proc Soc Exp Biol Med. 1970 Jun;134(2):499–503. doi: 10.3181/00379727-134-34821. [DOI] [PubMed] [Google Scholar]
  2. Beare A. S., Hobson D., Reed S. E., Tyrrell D. A. A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet. 1968 Aug 24;2(7565):418–422. doi: 10.1016/s0140-6736(68)90463-7. [DOI] [PubMed] [Google Scholar]
  3. Bellanti J. A., Sanga R. L., Klutinis B., Brandt B., Artenstein M. S. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med. 1969 Mar 20;280(12):628–633. doi: 10.1056/NEJM196903202801202. [DOI] [PubMed] [Google Scholar]
  4. Buser F. Side reaction to measles vaccination suggesting the Arthus phenomenon. N Engl J Med. 1967 Aug 3;277(5):250–251. doi: 10.1056/NEJM196708032770507. [DOI] [PubMed] [Google Scholar]
  5. CATE T. R., COUCH R. B., FLEET W. F., GRIFFITH W. R., GERONE P. J., KNIGHT V. PRODUCTION OF TRACHEOBRONCHITIS IN VOLUNTEERS WITH RHINOVIRUS IN A SMALL-PARTICLE AEROSOL. Am J Epidemiol. 1965 Jan;81:95–105. doi: 10.1093/oxfordjournals.aje.a120501. [DOI] [PubMed] [Google Scholar]
  6. CATE T. R., COUCH R. B., JOHNSON K. M. STUDIES WITH RHINOVIRUSES IN VOLUNTEERS: PRODUCTION OF ILLNESS, EFFECT OF NATURALLLY ACQUIRED ANTIBODY, AND DEMONSTRATION OF A PROTECTIVE EFFECT NOT ASSOCIATED WITH SERUM ANTIBODY. J Clin Invest. 1964 Jan;43:56–67. doi: 10.1172/JCI104894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CHANOCK R. M., PARROTT R. H. ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION. Pediatrics. 1965 Jul;36:21–39. [PubMed] [Google Scholar]
  8. COATES H. V., KENDRICK L., CHANOCK R. M. Antigenic differences between two strains of respiratory syncytial virus. Proc Soc Exp Biol Med. 1963 Apr;112:958–964. doi: 10.3181/00379727-112-28221. [DOI] [PubMed] [Google Scholar]
  9. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969 Apr;89(4):449–463. doi: 10.1093/oxfordjournals.aje.a120957. [DOI] [PubMed] [Google Scholar]
  10. Couch R. B., Douglas R. G., Jr, Fedson D. S., Kasel J. A. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis. 1971 Nov;124(5):473–480. doi: 10.1093/infdis/124.5.473. [DOI] [PubMed] [Google Scholar]
  11. De Clercq E., Nuwer M. R., Merigan T. C. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice. J Clin Invest. 1970 Aug;49(8):1565–1577. doi: 10.1172/JCI106374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Denny F. W. The replete pediatrician and the etiology of lower respiratory tract infections. Presidential address to the Society for Pediatric Research. Pediatr Res. 1969 Sep;3(5):464–470. doi: 10.1203/00006450-196909000-00010. [DOI] [PubMed] [Google Scholar]
  13. Finter N. B. Exogenous interferon in animals and its clinical implications. Arch Intern Med. 1970 Jul;126(1):147–157. [PubMed] [Google Scholar]
  14. Foy H. M., Cooney M. K., McMahan R., Bor E., Grayston J. T. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization. JAMA. 1971 Aug 23;217(8):1067–1071. [PubMed] [Google Scholar]
  15. Francis T., Jr THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS. Science. 1940 Feb 23;91(2356):198–199. doi: 10.1126/science.91.2356.198. [DOI] [PubMed] [Google Scholar]
  16. Fulginiti V. A., Arthur J. H. Altered reactivity to measles virus. Skin test reactivity and antibody response to measles virus antigens in recipients of killed measles virus vaccine. J Pediatr. 1969 Oct;75(4):609–616. doi: 10.1016/s0022-3476(69)80456-7. [DOI] [PubMed] [Google Scholar]
  17. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969 Apr;89(4):435–448. doi: 10.1093/oxfordjournals.aje.a120956. [DOI] [PubMed] [Google Scholar]
  18. Gardner P. S., McQuillin J., Court S. D. Speculation on pathogenesis in death from respiratory syncytial virus infection. Br Med J. 1970 Feb 7;1(5692):327–330. doi: 10.1136/bmj.1.5692.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gwaltney J. M., Jr, Hendley J. O., Simon G., Jordan W. S., Jr Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966 Dec 8;275(23):1261–1268. doi: 10.1056/NEJM196612082752301. [DOI] [PubMed] [Google Scholar]
  20. Gwaltney J. M., Jr, Hendley J. O., Simon G., Jordan W. S., Jr Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA. 1967 Nov 6;202(6):494–500. [PubMed] [Google Scholar]
  21. HILLEMAN M. R., HAMPARIAN V. V., KETLER A., REILLY C. M., McCLELLAND L., CORNFELD D., STOKES J., Jr Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. JAMA. 1962 May 12;180:445–453. doi: 10.1001/jama.1962.03050190007002. [DOI] [PubMed] [Google Scholar]
  22. Hamre D., Connelly A. P., Jr, Procknow J. J. Virologic studies of acute respiratory disease in young adults. IV. Virus isolations during four years of surveillance. Am J Epidemiol. 1966 Mar;83(2):238–249. doi: 10.1093/oxfordjournals.aje.a120579. [DOI] [PubMed] [Google Scholar]
  23. Hilleman M. R. Double-stranded RNAs (poly I:C) in the prevention of viral infections. Arch Intern Med. 1970 Jul;126(1):109–124. [PubMed] [Google Scholar]
  24. Kapikian A. Z., Mitchell R. H., Chanock R. M., Shvedoff R. A., Stewart C. E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969 Apr;89(4):405–421. doi: 10.1093/oxfordjournals.aje.a120954. [DOI] [PubMed] [Google Scholar]
  25. Kilbourne E. D., Schulman J. L., Schild G. C., Schloer G., Swanson J., Bucher D. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J Infect Dis. 1971 Nov;124(5):449–462. doi: 10.1093/infdis/124.5.449. [DOI] [PubMed] [Google Scholar]
  26. Kim H. W., Arrobio J. O., Pyles G., Brandt C. D., Camargo E., Chanock R. M., Parrott R. H. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics. 1971 Nov;48(5):745–755. [PubMed] [Google Scholar]
  27. Kim H. W., Bellanti J. A., Arrobio J. O., Mills J., Brandt C. D., Chanock R. M., Parrott R. H. Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med. 1969 Jun;131(2):658–661. doi: 10.3181/00379727-131-33946. [DOI] [PubMed] [Google Scholar]
  28. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  29. Leibovitz A., Coultrip R. L., Kilbourne E. D., Legters L. J., Smith C. D., Chin J., Schulman J. L. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees. J Infect Dis. 1971 Nov;124(5):481–487. doi: 10.1093/infdis/124.5.481. [DOI] [PubMed] [Google Scholar]
  30. Lindh H. F., Lindsay H. L., Mayberry B. R., Forbes M. Polyinosinic-cytidylic acid complex (poly I:C) and viral infections in mice. Proc Soc Exp Biol Med. 1969 Oct;132(1):83–87. doi: 10.3181/00379727-132-34153. [DOI] [PubMed] [Google Scholar]
  31. McIntosh K., Kapikian A. Z., Turner H. C., Hartley J. W., Parrott R. H., Chanock R. M. Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol. 1970 Jun;91(6):585–592. doi: 10.1093/oxfordjournals.aje.a121171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mogabgab W. J., Leiderman E. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. JAMA. 1970 Mar 9;211(10):1672–1676. [PubMed] [Google Scholar]
  33. PORTNOY B., ECKERT H. L., SALVATORE M. A. RHINOVIRUS INFECTION IN CHILDREN WITH ACUTE LOWER RESPIRATORY DISEASE: EVIDENCE AGAINST ETIOLOGICAL IMPORTANCE. Pediatrics. 1965 Jun;35:899–905. [PubMed] [Google Scholar]
  34. Peck F. B., Jr Purified influenza virus vaccine. A study of viral reactivity and antigenicity. JAMA. 1968 Dec 2;206(10):2277–2282. [PubMed] [Google Scholar]
  35. Perkins J. C., Tucker D. N., Knope H. L., Wenzel R. P., Hornick R. B., Kapikian A. Z., Chanock R. M. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol. 1969 Oct;90(4):319–326. doi: 10.1093/oxfordjournals.aje.a121076. [DOI] [PubMed] [Google Scholar]
  36. Potash L., Lees R. S., Greenberger J. L., Hoyrup A., Denney L. D., Chanock R. M. A mutant of Parainfluenza type 1 virus with decreased capacity for growth at 38 C and 39 C. J Infect Dis. 1970 Jun;121(6):640–647. doi: 10.1093/infdis/121.6.640. [DOI] [PubMed] [Google Scholar]
  37. REILLY C. M., HOCH S. M., STOKES J., Jr, McCLELLAND L., HAMPARIAN V. V., KETLER A., HILLEMAN M. R. Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. Ann Intern Med. 1962 Oct;57:515–525. doi: 10.7326/0003-4819-57-4-515. [DOI] [PubMed] [Google Scholar]
  38. Scott T. F., Bonanno D. E. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine. N Engl J Med. 1967 Aug 3;277(5):248–250. doi: 10.1056/NEJM196708032770506. [DOI] [PubMed] [Google Scholar]
  39. Smith C. B., Purcell R. H., Bellanti J. A., Chanock R. M. Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med. 1966 Nov 24;275(21):1145–1152. doi: 10.1056/NEJM196611242752101. [DOI] [PubMed] [Google Scholar]
  40. WULFF H., KIDD P., WENNER H. A. RESPIRATORY SYNCYTIAL VIRUS: OBSERVATIONS ON ANTIGENIC HETEROGENEITY. Proc Soc Exp Biol Med. 1964 Jan;115:240–243. doi: 10.3181/00379727-115-28880. [DOI] [PubMed] [Google Scholar]
  41. Waldman R. H., Mann J. J., Small P. A., Jr Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine. JAMA. 1969 Jan 20;207(3):520–524. doi: 10.1001/jama.207.3.520. [DOI] [PubMed] [Google Scholar]
  42. Wright P. F., Woodend W. G., Chanock R. M. Temperature-sensitive mutants of respiratory syncytial virus: in-vivo studies in hamsters. J Infect Dis. 1970 Dec;122(6):501–512. doi: 10.1093/infdis/122.6.501. [DOI] [PubMed] [Google Scholar]
  43. Wright P. F., v Mills J., Chanock R. M. Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J Infect Dis. 1971 Nov;124(5):505–511. doi: 10.1093/infdis/124.5.505. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES